Emergent BioSolutions Inc EBS
Morningstar Growth Grade = A
Projected Annual Return = 19.2%
June 22, 2021 price = $59.12
Company Profile
Business Description
Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products.
Contact400 Professional Drive, Suite 400
Gaithersburg, MD, 21079
Gaithersburg, MD, 21079
T +1 240 631-3200
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Most Recent EarningsMar 31, 2021
Fiscal Year EndDec 31, 2020
Stock TypeAggressive Growth
Employees2,200
No comments:
Post a Comment